Search
-
Business Travel Risks On The Rise Say Decision-Makers
In October 2016 Ipsos surveyed 1,119 people who organise, influence, or are responsible for, their organisation’s travel and risk mitigation policies.
-
Ipsos Launches Syndicated Social Listening in Healthcare
Deployed successfully, social listening can accelerate insight generation from any kind of text data: web forums, social media sites, survey verbatims, internal data, and much more.
-
New Research Shows Exercise Helps Cancer Patients Thrive
Cancer patients who otherwise would shy away from visiting the gym because of an altered appearance and lack of confidence are thriving as a result of an innovative 12-week exercise program.
-
Ethnography
Ethnography is a qualitative research technique, characterised by spending extended periods of time with people. We immerse ourselves in their world so we can observe and understand what they say, what they do and how they do it.
-
Ipsos Healthcare Launches ‘NASH’ Therapy Monitor
Ipsos Healthcare has launched its Nonalcoholic Steatohepatitis (NASH) Therapy Monitor in the US and EU5 initially – France, Germany, Italy, Spain, and UK – with other markets available on demand.
-
International Survey on Connected Health: Coming Ready or Not!
Connected Health – sometimes referred to as Digital Health – is a potential game-changer for global healthcare.
-
Who Will Win the Race to Treat NASH?
Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.
-
Harnessing Complexity: Companion Diagnostics in Oncology
As an increasing number of drugs gain approval for patients whose cancers have certain molecular characteristics, the promise of truly personalised medicine is edging closer towards reality.
-
Why Is It Such a Challenge to Treat PAH?
Pulmonary Arterial Hypertension (PAH) is a life-threatening, degenerative disease that severely compromises the function of both the pulmonary (lung) and cardiovascular (heart) systems. Despite current treatment options in PAH offering improvements in symptom control and quality of life factors, there continue to be significant challenges that compromise the effective management of this progressive and debilitating condition.
-
India: Consumed by a Health Wave
India lags behind the world when it comes to the tag of being a ‘healthy’ nation, with healthcare accounting for only 0.9 per cent of national GDP as against 12 per cent by G7 countries. Health as a topic has never been centre-stage in the larger discussions on the country’s progress and growth.